What Does a Genetic Blood Test Show for Pregnancy

A genetic blood test during pregnancy, commonly known as noninvasive prenatal testing (NIPT) or maternal carrier screening, analyzes cell-free fetal DNA circulating in the mother’s blood to screen for chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, trisomy 13, and sex chromosome aneuploidies. Depending on the panel, it may also detect microdeletions and assess the mother’s carrier status for inherited single-gene disorders like cystic fibrosis or spinal muscular atrophy. Today, advanced sequencing technologies allow these tests to cover hundreds of conditions with higher accuracy, yet they remain screening tools—not diagnostic—and require follow-up for confirmation.

Key Conditions Detected by Prenatal Genetic Blood Tests

Chromosomal Aneuploidies

The most common indications for a prenatal genetic blood test are the three major trisomies: trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). These conditions arise from an extra copy of a chromosome and are detected with >99% sensitivity for trisomy 21 in most NIPT panels. Today, expanded panels also include trisomies 9, 16, and 22, though these are rarer.

Sex Chromosome Abnormalities

NIPT can identify sex chromosome aneuploidies such as Turner syndrome (monosomy X), Klinefelter syndrome (XXY), Triple X syndrome (XXX), and Jacobs syndrome (XYY). While detection rates are high, positive results should be validated with diagnostic testing due to potential false positives from maternal mosaicism.

Microdeletions

Some advanced NIPT panels screen for microdeletion syndromes like 22q11.2 deletion (DiGeorge syndrome), 1p36 deletion, and Prader-Willi/Angelman syndromes. These deletions are too small for standard karyotyping but can be identified by high-depth sequencing. However, positive predictive values vary widely; genetic counseling is essential.

Single-Gene Disorders (Carrier Screening)

Separate from NIPT, a maternal blood draw can be used for expanded carrier screening—testing the mother for over 100 recessive conditions. If she is a carrier, the biological father is often tested to determine the recurrence risk. Disorders include cystic fibrosis, spinal muscular atrophy, Tay-Sachs disease, and fragile X syndrome. This screening does not analyze fetal DNA directly but informs the couple's reproductive options.

What a Genetic Blood Test Cannot Reveal

• Structural birth defects (e.g., heart defects, neural tube defects) — these require ultrasound or maternal serum AFP testing.
• Open neural tube defects like spina bifida — NIPT does not analyze amniotic fluid alpha-fetoprotein.
• All chromosomal abnormalities — standard panels miss low-level mosaicism and balanced translocations.
• Single-gene disorders in the fetus unless the panel specifically includes them (most NIPT panels do not cover de novo mutations).
• Guaranteed diagnosis — every positive screen must be confirmed by amniocentesis or chorionic villus sampling (CVS).

Comparison of Prenatal Genetic Test Types

The table below summarizes the difference between the two main blood-based tests and diagnostic procedures.

Accuracy and Limitations of Genetic Blood Tests today

While NIPT boasts detection rates above 99% for trisomy 21, it is not diagnostic. Positive predictive value (PPV) depends on the prevalence of the condition and maternal age. For example, in a 25-year-old woman, the PPV for trisomy 21 may be around 50%, meaning half of positive results are false alarms. Today, laboratories use larger reference databases and refined algorithms to minimize false positives, but confirmatory testing remains mandatory. Additionally, maternal obesity, multiple gestations, and vanishing twin syndrome can affect fetal fraction and accuracy. Carrier screening has similarly high sensitivity but requires the partner's test to complete risk assessment.

When Should You Consider a Genetic Blood Test?

The American College of Obstetricians and Gynecologists now recommends that all pregnant individuals be offered NIPT as a primary screening option, regardless of age. However, it is especially valuable for women over 35, those with a family history of genetic disorders, or previous pregnancy with aneuploidy. Carrier screening is typically offered preconception or early in pregnancy. Genetic counseling should accompany all positive results to discuss next steps.

How to Order a Genetic Blood Test

If you're ready to gain clarity about your pregnancy's genetic health, explore our comprehensive prenatal genetic panel at geneticpanels.com. Order your test today at /order/prenatal-genetic-panel and receive results with expert genetic counseling support.

Frequently Asked Questions

What does a genetic blood test show for pregnancy?

A genetic blood test in pregnancy screens for chromosomal abnormalities (like Down syndrome) and, in some panels, microdeletions or maternal carrier status for inherited conditions. It analyzes cell-free fetal DNA from a maternal blood sample and is safe for both mother and baby.

How accurate is NIPT today?

NIPT has >99% sensitivity for trisomy 21, with specificity above 99.9%. However, positive predictive values are lower for rarer conditions, so confirmatory diagnostic testing is required for any positive result.

Is a genetic blood test safe for the baby?

Yes—the test uses a simple maternal blood draw, with no risk to the fetus. It is noninvasive and carries no chance of miscarriage, unlike amniocentesis or CVS.

Do I need carrier screening in addition to NIPT?

Carrier screening is separate and detects recessive disorders you may carry. It is recommended for all women planning pregnancy or early in pregnancy, regardless of NIPT results.